Team

We have gathered a very experienced
and motivated team of managers and external advisors

  • Adam Kruszewski

    MD, MBA

  • Artur Płonowski

    MD, PhD

  • Jarosław Leszczyszyn

    MD, PhD, MBA

  • Wojciech Tomikowski

    MSc

  • Artur Brus

    MA MSc LLM

  • Jan Gruszczyński

    BSc

    • Adam Kruszewski, MD, MBA

      Chief Executive Officer

      Warsaw, Poland, MD, MBA

      Chief Executive Officer
      20+ years of international experience (pharma, health care sector, PE, VC)
      C- level executive with track record of successful turnarounds (Luxmed (Bupa Group), Medicover $1B, Medycyna Rodzinna)
      Built/sold own international business KCR, a leading CRO in the region
      Set up influential health care think tank (CEE HPN)
      Advisor and investor in unicorn Doc Planner

    • Artur Płonowski, MD, PhD

      20+ years of drug discovery and development in biotech and global pharma industry – Exelixis, Takeda, Akarna, Allergan
      Co-founder of US companies (Seal Rock Therapeutics and Vasa Therapeutics)
      Hands-on experience in project value creation through selection of the most efficient strategies to demonstrate clinical safety and efficacy.
      Track record of successful exits transactions with big pharma

    • Jarosław Leszczyszyn, MD, PhD, MBA

      Entrepreneur, hospital and outpatient medical business ( EMC IM SA, EMC HC Ltd ( Ireland), PSMS Ltd (Ireland)
      Co-founder/former deputy CEO EMC Instytut Medyczny SA( public listed company-private hospitals network)
      Former professor of gastroenterology, National Institute for Rheumatology and Rehabilitation, Warsaw
      25 years of experience in more than 50 clinical trials as PI and national coordinator (autoimmune diseases, gastroenterology, pain medicine, oncology, infectious diseases)

    • Wojciech Tomikowski, MSc

      20y+ experience/ C- level executive e.g. in Novartis Consumer Health
      General Management international experience in turnarounds/bd/M&A (South America, China, Russia and Europe)
      Partner in PE/VC, owner of a M&A advisory boutique
      Executive education programs at HBS, Wharton, LBS

    • Artur Brus, MA MSc LLM

      Vice President at Citibank
      Co-founder of Clinical Servant, which is developing Smart Container for Clinical Trials (SCCT)
      A graduate of the University of Cambridge and the University of Copenhagen
      Completed the ‘From Idea to Health Business Programme’ at Imperial College Business School

    • Jan Gruszczyński, BSc

      MEng Master in Engineering 4th year, University of Oxford – specialising in software & electrical engineering
      Financial analysis experience in City of London M&A boutique, and in University of Oxford
      Internship in BCG and Bain
      Mentee of Oxford, Yale University, Boston Consulting Group, Tauron Poland, American Chamber of Commerce

    3

    Scientific Board

    • Leszek Lisowski

      PhD, MBA

      • Leszek Lisowski, PhD, MBA

        Founder of LogicBio, a Nasdaq listed $ 0.5B company
        Associate professor University of Sydney, Children’s Medical Research Institute (CMRI) in Australia
        Expert in viral gene therapy, vectorology and genotoxicity (developed novel lentiviral and AAV vectors)
        Established a Vector and Genome Engineering Facility at CMRI

      3

      Business Advisory

      • Tomasz Rejman

      • Łukasz Olek

        MEng

      • Piotr Hammer

        MD

        • Tomasz Rejman,

          SVP of McKinsey Restructuring in London
          Lead improvement projects for main Polish Oncological Centers
          Former COO of Allianz Poland, Cersanit (consumer goods) and PKN ORLEN (chemicals)
          30 years of C-level experience in business development, turnaround/ restructuring and performance improvement across a variety of industries and continents

        • Łukasz Olek, MEng

          Advisor – investor and entrepreneur with IT background with over 10 years of experience
          In 2010 co-founded and managed first online currency exchange business in Poland (internetowykantor.pl and walutomat.pl) that grew up to 100 people and 1B PLN monthly turnover. Successfully exited in 2017
          Since 2017 investor and advisor in multiple technology startups

        • Piotr Hammer, MD

          Active participant in the medical market in Poland since 1991
          CEO & Founder (2002) of HammerMed Medical Polska Ltd LLP (one of the leading supplier of medical devices in Poland)
          CEO & Founder (2009) of HammerMed II Nieruchomosci Ltd LLP
          Expert in introducing minimal invasive devices into the market
          Co-author of articles on the treatment of thoraco-abdominal aneurysms

        3